← Back to headlines
Amgen Raises 2026 Guidance After Strong Q2 Performance
Biotechnology giant Amgen has increased its earnings per share and revenue guidance for 2026, following a second quarter that surpassed analyst expectations on both financial metrics.
4 Aug, 22:42 — 4 Aug, 22:42
Sources
Showing 1 of 1 sources